Stacey Bilinski
Chief Tech/Sci/R&D Officer at IN8BIO, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Ho | M | 48 | 6 years | |
Patrick McCall | M | - | 3 years | |
Peter Brandt | M | 67 | 5 years | |
Alan Roemer | M | 54 | 4 years | |
Emily Fairbairn | F | 62 | 3 years | |
Travis Whitfill | M | 34 | 6 years | |
Luba Greenwood | F | 45 | 3 years | |
Lawrence Lamb | M | 70 | 6 years | |
Kate Rochlin | M | - | 4 years | |
Corinne Epperly | M | 46 | 1 years | |
Jeremy Graff | M | - | 1 years | |
Trishna Goswami | M | - | 3 years | |
Urvashi Patel | M | - | 2 years | |
Kenneth R. LaMontagne | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Vojislav Vukovic | M | 57 |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 1 years |
Susan Romanus | F | 58 |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 3 years |
Robert Chen | M | - |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 17 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stacey Bilinski
- Personal Network